Actuate Therapeutics Inc (ACTU) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 8.52M | 13.64M | 17.44M | 6.69M | 4.25M | 9.21M | 14.26M | 549.69K | 2.19M | 3M | 0 |
| Cash & Short-Term Investments | 8.13M | 13.16M | 16.92M | 6.49M | 3.89M | 8.64M | 13.52M | 351.71K | 2.07M | 2.96M | 0 |
| Cash Only | 8.13M | 13.16M | 16.92M | 6.49M | 3.89M | 8.64M | 13.52M | 351.71K | 2.07M | 2.96M | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 385.44K | 484K | 0 | 0 | 359.16K | 0 | 739.33K | 197.98K | 119.77K | 36.91K | 0 |
| Total Non-Current Assets | 391.84K | 392.49K | 269.93K | 280.34K | 234.47K | 110.55K | 0 | 1.18M | 510.5K | 0 | 0 |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 391.84K | 392.49K | 269.93K | 280.34K | 234.47K | 110.55K | 0 | 1.18M | 510.5K | 0 | 0 |
| Total Assets | 8.91M | 14.04M | 17.71M | 6.97M | 4.48M | 9.32M | 14.26M | 1.73M | 2.7M | 3M | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 98.78% | 50.63% | 24.2% | 302.63% | 66.13% | 211.07% | - | - | - | - | - |
| Total Current Liabilities | 4.72M | 5.71M | 6.37M | 9.2M | 9.15M | 8.8M | 8.5M | 20.07M | 14.73M | 6.92M | 0 |
| Accounts Payable | 1.2M | 1.52M | 1.25M | 3.17M | 2.64M | 1.92M | 2.33M | 5.89M | 3.96M | 3.42M | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6.9M | 5M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 3.52M | 4.18M | 0 | 0 | 1.24M | 0 | 0 | 277.5K | 277.5K | 277.5K | 0 |
| Current Ratio | 1.80x | 2.39x | 2.74x | 0.73x | 0.46x | 1.05x | 1.68x | 0.03x | 0.15x | 0.43x | - |
| Quick Ratio | 1.80x | 2.39x | 2.74x | 0.73x | 0.46x | 1.05x | 1.68x | 0.03x | 0.15x | 0.43x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 404.99K | 404.99K | 404.99K | 421.88K | 416.82K | 411.76K | 406.68K | 95.91M | 95.74M | 95.7M | 0 |
| Long-Term Debt | 404.99K | 404.99K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 404.99K | 421.88K | 416.82K | 411.76K | 406.68K | 95.91M | 95.74M | 95.7M | 0 |
| Total Liabilities | 5.13M | 6.11M | 6.78M | 9.62M | 9.57M | 9.21M | 8.9M | 115.99M | 110.47M | 102.62M | 0 |
| Total Debt | 404.99K | 404.99K | 0 | 0 | 0 | 0 | 0 | 6.9M | 5M | 0 | 0 |
| Net Debt | -7.73M | -12.75M | -16.92M | -6.49M | -3.89M | -8.64M | -13.52M | 6.55M | 2.93M | -2.96M | 0 |
| Debt / Equity | 0.11x | 0.05x | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -1127.21x | -926.05x | -1067.04x | -1174.31x | -1246.68x | -1268.92x | -1710.37x | -1293.76x | -1633.37x | -1502.49x | - |
| Total Equity | 3.78M | 7.92M | 10.94M | -2.65M | -5.09M | 104.19K | 5.36M | -114.26M | -107.77M | -99.63M | 0 |
| Equity Growth % | 174.38% | 7505.63% | 104.09% | 97.68% | 95.28% | 100.1% | - | - | - | - | - |
| Book Value per Share | 0.16 | 0.34 | 0.51 | -0.14 | -0.26 | 0.01 | 0.27 | -5.85 | -6.96 | -6.53 | - |
| Total Shareholders' Equity | 3.78M | 7.92M | 10.94M | -2.65M | -5.09M | 104.19K | 5.36M | -114.26M | -107.77M | -99.63M | 0 |
| Common Stock | 24 | 23 | 23 | 20 | 20 | 20 | 20 | 2 | 2 | 2 | 0 |
| Retained Earnings | -160.23M | -154.61M | -150.05M | -144.65M | -138.7M | -132.38M | -125.93M | -119.96M | -113.39M | -105.09M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |